Lekha Mikkilineni, MD¹, Elisabet E. Manasanch, M.D.², Danielle Natrakul, BS^3*, Katherine Weissler, PhD^4*, Jennifer N. Brudno, MD³, Jennifer Mann, CRNP^3*, Stephanie L Goff, MD^5*, James C Yang, MD^6*, Norris Lam, BS^3*, Irina Maric, MD, MSci⁷, Hao-Wei Wang, MD, PhD⁸, Constance M. Yuan, MD, PhD^9*, David F. Stroncek, MD¹⁰, Steven Highfill, PhD^10*, Micaela Ganadan, BSN, RN^5*, Rashmika Patel^11*, Steven A Rosenberg, MD, PhD^12* and James N. Kochenderfer, MD³

¹Surgery Branch, National Cancer Institute, National Institutes of Health, Washington, DC
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁴Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁵Surgery Branch, National Cancer Institute, Bethesda, MD
⁶Surgery Branch, National Cancer Institute, Maryland
⁷Department of Laboratory Medicine, National Institutes of Health, Bethesda, MD
⁸Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁹Laboratory of Pathology, National Cancer Institute, Bethesda, MD
¹⁰Center for Cellular Engineering, National Institutes of Health, Bethesda, MD
¹¹Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
¹²Surgery Branch, National Cancer Institute, Bethesda

Chunrui Li, MD, PhD¹, Di Wang, M.D., Ph.D.^1*, Baijun Fang, M.D., Ph.D.^2*, Yongping Song, M.D., Ph.D.^2*, He Huang³, Jianyong Li, MD⁴, Dehui Zou, M.D., Ph.D.^5*, Bing Chen, M.D., Ph.D.^6*, Jing Liu, M.D., Ph.D.^7*, Yujun Dong^8*, Hanyun Ren, M.D., Ph.D.⁸, Kai Hu, M.D., Ph.D.^9*, Peng Liu, MD¹⁰, Xi Zhang, M.D., Ph.D.^11*, Jian-Qing Mi, M.D., Ph.D.^12*, Zhenyu Li, M.D., Ph.D.^13*, Kaiyang Ding, M.D., Ph.D.^14*, Jue Wang, M.D., Ph.D.^1*, Liting Chen, Ph.D.^1*, Aining Xu, M.D., Ph.D.^15*, Songbai Cai^15*, Jingwen Zeng^15*, Jingjing Guo, Ph.D.^15*, Hongyu Gui^15*, Wen Wang, M.D., Ph.D.^15* and Lugui Qiu⁵

¹Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
²Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
³Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
⁴Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
⁶Department of Hematology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing210008, Jiangsu, People’s Republic of China, Nanjing, China
⁷Department of Hematology, Third Xiangya Hospital of Central South University, Changsha, China
⁸Department of Hematology, Peking University First Hospital, Beijing, China
⁹Department of Adult Lymphoma, Beijing GoBroad Boren Hospital, Beijing, China
¹⁰Department of Hematology, Zhongshan Hospital Fudan University, Shanghai, China
¹¹Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China
¹²Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
¹³The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
¹⁴Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
¹⁵Nanjing IASO Biotherapeutics Ltd, Nanjing, China

Matthew C. Foster, MD¹, Barbara Savoldo, MD, PhD^1*, Winnie Lau, MD^2*, Clio Rubinos, MD, MS^2*, Natalie S. Grover, MD¹, Paul M. Armistead, MD, PhD^1*, James M. Coghill Jr., MD¹, Katarzyna Joanna Jamieson, MD^1*, Robert Hagan, MD, PhD^3*, J. Kaitlin Morrison, PhD^1*, Faith Brianne Buchanan, PA-C^4*, Catherine Joyce Arago Cheng, BS^1*, Anastasia Ivanova, PhD^1*, Tammy Cavallo, BS^1*, John West, PhD^1*, Megan Gonzalez^4*, Jonathan S. Serody, MD⁵ and Gianpietro Dotti, MD^1*

¹Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
²Department of Neurology, University of North Carolina School of Medicine, Chapel Hill, NC
³University of North Carolina Marsico Lung Institute, Chapel Hill, NC
⁴UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
⁵Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC

Matthew Frigault, MD, MS¹, Jacalyn Rosenblatt, MD², Binod Dhakal, MBBS³, Noopur Raje, MD⁴, Daniella Cook, BS^5*, Mahmoud R. Gaballa, MD⁶, Estelle Emmanuel-Alejandro^7*, Danielle Nissen^8*, Christine Cornwell^9*, Kamalika Banerjee^9*, Anand Rotte, PhD^9*, Christopher R. Heery, MD⁹, David Avigan, MD¹⁰, Andrzej Jakubowiak, MD, PhD¹¹ and Michael R. Bishop, MD¹²

¹Massachusetts General Hospital, Dorchester, MA
²Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
³Medical College of Wisconsin, Division of Hematology/Oncology, Department of Medicine, Milwaukee, WI
⁴Mass General Hospital Cancer Center, Boston, MA
⁵Cancer Center, Massachusetts General Hospital, Boston, MA
⁶Massachusetts General Hospital, Boston, MA
⁷Massachusetts General Hospital Cancer Center, Boston
⁸Medical College of Wisconsin, Milwaukee
⁹Arcellx, Inc., Gaithersburg, MD
¹⁰Beth Israel Deaconess Medical Center, Boston, MA
¹¹Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, IL
¹²The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL

Madhav Dhodapkar, MBBS¹, Melissa Alsina, MD**², Jesus Berdeja, MD³, Krina Patel, MD, MSc⁴, Ravi Vij, MD, MBBS⁵, Xavier Leleu, MD, PhD⁶, Anna Truppel-Hartmann, MD^7*, Debashree Basudhar, PhD^8*, Ethan Thompson, PhD^8*, Xirong Zheng, PhD^8*, Revathi Ananthakrishnan, PhD^8*, Linda Favre-Kontula, PhD^8*, Chiara Greggio, PhD^8*, Lars Sternas, MD, PhD^8* and David Samuel Siegel, MD, PhD⁹

¹Emory University, Atlanta, GA
²Moffitt Cancer Center, Tampa, FL
³Sarah Cannon Research Institute, Nashville, TN
⁴Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Washington University in St. Louis, St. Louis, MO
⁶CHU La Milétrie, Poitiers, France
⁷2seventy bio, Cambridge, MA
⁸Bristol Myers Squibb, Princeton, NJ
⁹Hackensack University John Theurer Cancer Center, Hackensack, NJ

Shambavi Richard, MD¹, Guido Lancman, MD, MSc^2,3, Santiago Thibaud, MD⁴, Ajai Chari, MD⁵, Samir Parekh, MD², Adriana Rossi, MD, MSc⁶, Hearn J. Cho, MD, PhD⁴, Larysa Sanchez, MD^4*, Joshua Richter, MD⁷, Cesar Rodriguez, MD^4*, Elizabeth Aronson, NP^8*, Karen Louw, NP^7*, Kiah Purcell, NP^7*, Daniel Verina, ANP^9*, Juliet Escalon, NP^8* and Sundar Jagannath¹⁰

¹Tisch Cancer Institute, Mount Sinai Health System, Bronx, NY
²Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY
³University Health Network, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁴Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁵Department of Hematology and Medical Oncology, Tisch Cancer Institute, Mount Sinai School of Medicine, New York, NY
⁶Icahn School of Medicine, Mount Sinai Hospital, New York, NY
⁷Mount Sinai School of Medicine, New York, NY
⁸Mount Sinai Hospital, New York, NY
⁹Mount Sinai Medical Center, New York, NY
¹⁰Department of Medicine, Hematology and Medical Oncology, Mount Sinai Medical Center, New York, NY

Alexandre Vinaud Hirayama, MD¹, Salvatore Fiorenza, PhD, BSc, FRACP, FRCPA, MBBS, MPH¹, Jordan Gauthier, MD¹, Jenna M. Voutsinas, MPH^1*, Qian Vicky Wu, PhD^1*, Erik L. Kimble, MD¹, Barbara S. Pender, MSc^1*, Delaney R. Kirchmeier, BSc^1*, Henna A. Di, BSc^1*, Ryan D. Cassaday, MD², Aude G. Chapuis, MD¹, Damian J. Green, MD³, Hans-Peter Kiem, MD, PhD¹, Filippo Milano, MD¹, Mazyar Shadman, MD¹, Brian G. Till, MD¹, Stanley R. Riddell, MD¹, David G. Maloney, MD, PhD¹ and Cameron J. Turtle, MBBS, PhD¹

¹Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
²UW/FHCRC, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Ruihao Huang^1*, Qin Wen, MD^1*, Xiaoqi Wang, MD^1*, Hongju Yan^1*, Yingying Ma^1*, Wang Mai-Hong^1*, Xiao Han^2*, Li Gao^2*, Lei Gao^2*, Cheng Zhang, MD, PhD^3* and Xi Zhang, MD, PhD^1*

¹Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, China
²Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, chongqing, China
³Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, Chongqing, China

Claire Roddie^1*, Juliana Dias Alves Pinto, PhD^2*, Maeve A O'Reilly¹, Marina Mitsikakou, BSc; MSc^3*, Eftychia Charalambous, BSc(Hons); MSc^4*, Louisa Green, BSc^3*, Mhairi Vaughan, BSc; MSc^3*, Giulia Agliardi, BSc(Hons); PhD^4*, John Garcia, BSc(Hons); PhD^4*, Evie Lewin, BSc(Hons); MSc^4*, Mark W. Lowdell, PhD, FRCPath, FRSB^5*, Maria A V Marzolini^6*, Leigh Wood, BA^7*, Helen Holmes, BSc(Hons); MSc^8*, Yenting Ngai, PhD^9*, Bilyana Popova, MSc^10*, William Wilson^11*, Sangeetha Kunaseelan^12*, Victoria Spanswick^13*, Helen Lowe^3*, Leah Ensell^14*, John A. Hartley, PhD^13*, Simon Morley^15*, David C. Linch^16*, Adrian Bloor, PhD FRCP FRCPath^17*, David A. Irvine, BSc, MBBChir, MRCP, FRCPath, PhD¹⁸, Martin Pule, MD, PhD^4* and Karl S Peggs, MD, PhD^19*

¹University College London Hospital NHS Foundation Trust, London, United Kingdom
²UCL Cancer INstitute, london, United Kingdom
³UCL Cancer Institute, University College London, London, United Kingdom
⁴Cancer Institute, University College London, London, United Kingdom
⁵Cancer Institute, University College London, London, GBR
⁶Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁷University College London Hospital, London, United Kingdom
⁸CRUK UCL Cancer Trials Centre, University College London, London, United Kingdom
⁹UCL CRUK Cancer Trials Centre, University College London, London, United Kingdom
¹⁰CRUK UCL Cancer Trials Centre, UCL, London, United Kingdom
¹¹UCL Cancer Trials Centre, London, United Kingdom
¹²CRUK Cancer Trials Centre, University College London, London, United Kingdom
¹³UCL Cancer Institute, London, United Kingdom
¹⁴UCL ECMC GCLP Laboratory, University College London, London, United Kingdom
¹⁵University College London Hospitals NHS Trust, London, United Kingdom
¹⁶University College London, London, United Kingdom
¹⁷Haematology, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom
¹⁸Queen Elizabeth University Hospital, Glasgow, Scotland, GBR
¹⁹University College London Cancer Institute, London, United Kingdom

Matthew S. Davids, MD¹, Saad S. Kenderian, MD², Ian W. Flinn, MD PhD³, Brian T. Hill, MD, PhD⁴, Michael Maris, MD⁵, Paolo Ghia, MD, PhD⁶, Michael Byrne, DO⁷, Nancy L. Bartlett, MD⁸, John M. Pagel, MD, PhD⁹, Yan Zheng, MS^10*, Justyna Kanska, PhD^10*, Wangshu Zhang, PhD^10*, Behzad Kharabi Masouleh, MD^10*, Enrique Granados, MD, SH^10* and Javier Pinilla Ibarz, MD¹¹

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
²Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
³Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN
⁴Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
⁵Sara Cannon Research Institute, Denver, CO
⁶Universita' Vita-Salute San Raffaele C.F. 97187560152, Milano, MI, Italy
⁷Department of Medicine, Division of Hematology and Oncology, Vanderbilt University, Nashville, TN
⁸Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
⁹Divison of Oncology, University of Washington School of Medicine, Swedish Cancer Institute, Seattle, WA
¹⁰Kite, a Gilead Company, Santa Monica, CA
¹¹Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL

Paolo F Caimi, MD¹, Martina Di Trani^2*, Armin Ghobadi, MD³, Jane Reese^4*, Benjamin Tomlinson, MD⁵, Folashade Otegbeye, MBBChir, MPH⁶, Kirsten M Boughan, DO⁷, Molly Gallogly, MD, PhD⁸, Leland Metheny, MD⁹, Brenda W. Cooper, MD¹⁰, Boro Dropulic, PhD, MBA^11*, Marcos J.G. de Lima, MD¹² and Carmelo Carlo-Stella, MD, PhD¹³

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Humanitas Clinical and Research Center, Rozzano, MI, ITA
³Center for Gene and Cellular Immunotherapy (CGCI), Washington University School of Medicine, St. Louis, MO
⁴Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Cleveland, OH
⁵University Hospitals of Cleveland, Cleveland, OH
⁶Fred Hutchinson Cancer Research Center, SEATTLE, OH
⁷Louis Stokes Cleveland VA Medical Center, Cleveland, OH
⁸University Hospitals Seidman Cancer Center, Cleveland, OH
⁹Adult Hematologic Malignancies & Stem Cell Transplant Section, University Hospitals Seidman Cancer Center, Shaker Heights, OH
¹⁰Adult Hematologic Malignancies & Stem Cell Transplant Section, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH
¹¹Caring Cross, Gaithersburg, MD
¹²Blood and Marrow and Cellular Therapy Program, Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
¹³Humanitas University and IRCCS Humanitas Research Hospital, Milan, Milano, Italy

George Mo, MD¹, Sang Yun Lee, PhD^2*, David G. Coffey, MD^1,3*, Valentin Voillet, PhD^4,5*, IIan Kirsch, MD⁶, Damian J. Green, MD^1,7, Raphael Gottardo, PhD^4,8*, David G. Maloney, MD, PhD^1,2, Oliver W. Press, MD, PhD^1,2 and Brian G. Till, MD^1,2

¹Department of Medicine, University of Washington, Seattle, WA
²Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
³University of Miami, Miami, FL
⁴Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵Cape Town HVTN Immunology Laboratory, Hutchinson Centre Research Institute of South Africa, Cape Town, South Africa
⁶Adaptive Biotechnologies, Seattle, WA
⁷Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
⁸University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland

Yuchen Liu, MSc^1*, Jingfu Wang, MD^2*, Suyi Kang, MD^2*, Rui Zhang, MSc^1* and Lung-Ji Chang, PhD¹

¹Geno-Immune Medical Institute, Shenzhen, China
²Department of Pediatric Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, China

Joseph P. McGuirk, DO¹, Sunil H Abhyankar, MD^1,2, Trishna Goswami, MD^3*, Rupal Soder, PhD^4*, Mariska ter Haak^3*, Tyce Bruns^5*, Samantha Langford Youngblood, BS^6* and Lawrence S. Lamb Jr., PhD³

¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
²University of Kansas Cancer Center, Westwood, KS
³In8bio, Inc., New York, NY
⁴Midwest Stem Cell Therapy Center, Kansas City, KS
⁵Clinical Trial Office, University of Kansas Medical Center, Fairway, KS
⁶1500 First Avenue North, Suite 103, In8bio, Birmingham, AL

Michael P. Chu, MD¹, Zack M. Breckenridge, BSc^2*, Andrew Daly, MD³, Mona Shafey, MD⁴, Victor A. Lewis, MD⁵, Sunil J. Desai, MRCP, FRCPC, BM, BCh⁶, Peng Wang, MD, PhD⁷, Joseph Brandwein, MD⁸, Peter Duggan, MD, FRCPC⁴, Beverly Wilson^9*, Bindu Thapa^10*, Carina Debes-Marun^10* and Irwindeep Sandhu, MD^11*

¹Department of Oncology, Cross Cancer Institute, Edmonton, AB, Canada
²Cross Cancer Institute, Edmonton, AB, Canada
³Tom Baker Cancer Center, Calgary, AB, CAN
⁴Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
⁵Alberta Children's Hospital, University of Calgary, Calgary, AB, Canada
⁶Department of Pediatric Hematology-Oncology, University of Alberta/Stollery Children's Hospital, Edmonton, AB, Canada
⁷Department of Medicine, University of Alberta, Edmonton, AB, Canada
⁸Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada
⁹University of Alberta/Stollery Children's Hospital, Edmonton, AB, Canada
¹⁰University of Alberta, Edmonton, AB, Canada
¹¹Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

Ran Reshef, MD^1*, Hyung C. Suh, MD, PhD^2*, Monzr M. Al Malki, MD³, Aasiya Matin, MD^4*, Ashish S Kothari, MD, MS⁵, Allison Bell, PharmD^6*, Antoine J Boudot, Ph.D.^7*, Yun Wang, PhD^7*, Nina Abelowitz, ANP/Clinical Scientist^7*, James Murray^7*, Gavin Macbeath, PhD^7*, Debora Barton, MD^7* and Shrikanta Chattopadhyay, MD⁷

¹Columbia University Medical Center, New York, NY
²John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
³Department of Hematology/HCT, City of Hope, Duarte, CA
⁴Department of Oncology, Blood and Marrow Stem Cell Transplant Program, Karmanos Cancer Institute/Wayne State University, Detroit, MI
⁵Clinical Development, CareDx, Inc., Brisbane, CA
⁶CareDx, Inc., Brisbane, CA
⁷TScan Therapeutics, Waltham, MA

Zhitao Ying^1*, Keshu Zhou^2*, Lanfang Li^3*, Wenyu Li⁴, Su Yang^5*, Yun Liu^5*, Yongen Gu^5*, Zisong Zhou^5*, Alex Tian^5*, Yuqin Song, MD¹ and Jun Zhu, PhD¹

¹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
²Department of Hematology, Henan Cancer Hospital, Zhengzhou, China
³Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁴Department of Lymphoma, Guangdong Academy of Medical Science, Guangdong Provincial People's Hospital, Guangdong, China
⁵JW Therapeutics (Shanghai) Co. Ltd, Shanghai, China

Wei Liu^1*, Hesong Zou^1*, Yan Xu, MD^1*, Huimin Liu^1*, Chenxing Du, MD^1*, Rui Lv^1*, Wenyang Huang, MD^1*, Weiwei Sui^1*, Shuhua Yi, MD^1*, Lulu Lv, PhD^2*, Lugui Qiu¹, Jianxiang Wang, MD¹ and Dehui Zou^1*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
²Juventas Cell Therapy Ltd., Tianjin, China

Sumithira Vasu, MBBS¹, Lapo Alinari, MD, PhD², Nicole Szuminski, BS^3*, Dina Schneider^4*, Nathan Denlinger, MS, DO¹, Wing Keung Chan, PhD^1*, Khalid Parris, MBA^5*, Nidhi Sharma, PhD^6*, Hillary Bradbury^7*, Beth Daneault^8*, Lynn O'Donnell, PhD^9*, Boro Dropulic, PhD, MBA^10* and Marcos J.G. de Lima, MD¹¹

¹Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
²Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
³The Ohio State University, Columbus, OH
⁴A Miltenyi Biotec Company, Lentigen Technology Inc., Gaithersburg, MD
⁵James Cell Therapy Laboratory, The Ohio State University,, Columbus, OH
⁶Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH
⁷James Cell Therapy Laboratory, The Ohio State University, Columbus, OH
⁸ames Cell Therapy Laboratory, The Ohio State University, Columbus, OH
⁹Comprehensive Cancer Center, Ohio State University Medical Center - James Cancer Hospital, Columbus, OH
¹⁰Caring Cross, Gaithersburg, MD
¹¹Blood and Marrow and Cellular Therapy Program, Department of Internal Medicine, Division of Hematology, The Ohio State University, Columbus, OH

Anthony S. Stein, MD¹, Ashish Bajel, MBBS, DM², Shaun Fleming, FRACP FRCPA^3*, Mojca Jongen-Lavrencic⁴, Sylvain Garciaz, MD PHD^5*, Abhishek Maiti, MBBS⁶, Nicolas Boissel, MD, PhD⁷, Stephane De Botton, MD, PhD^8*, Gerwin A. Huls, MD, PhD⁹, David C. de Leeuw, MD, PhD^10*, David Avigan, MD¹¹, Kyle Jensen^12*, Brigitte Demers^13*, Timothy Wagenaar^12*, Gu Mi^12*, Samira Ziti-Ljajic^14*, Dobrin Draganov^12*, Giovanni Abbadessa¹² and Andrew H Wei¹⁵

¹Gehr Family Leukemia Center, City of Hope, Duarte, CA
²Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia
³Department of Haematology, Alfred Health, Melbourne, VIC, Australia
⁴Department of Hematology, Erasmus University Medical Center, Rotterdam, Netherlands
⁵Aix-Marseille University, INSERM U1068, CNRS, Institut Paoli-Calmettes, Marseille, France
⁶Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Hôpital Saint-Louis, Paris, France
⁸Institut Gustave Roussy, Villejuif, France
⁹Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
¹⁰Department of Hematology, Amsterdam University Medical Center, location VUMC, Amsterdam, Netherlands
¹¹Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA
¹²Sanofi, Cambridge, MA
¹³Sanofi, Vitry-Sur-Seine, France
¹⁴Sanofi, Chilly-Mazarin, France
¹⁵Department of Clinical Haematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia

Sunil Bhat, MBBS, MD^1*, Sharat Damodar, MBBS, MD, DM¹, Pooja Mallya^1*, Akshatha Nayak, MD DM^1*, Ravi Joshi^1*, Bharath Ram S, MBBS, DNB¹, Sudarshan Chougule^1*, Deepak MB, MD, MBBS^1*, Gopinadh Jakka^2*, Sudeshna Dhar^2*, Anne Roshan Joseph^2*, Arun Kumar MG^2*, Murugan Palanisamy^2*, Jeetendra Kumar^2*, Melina Soares^2*, Pallavi Arasu^2*, Sri Ramulu Elluru^2*, Mohammed Manzoor Akheel, MPH MBA^2* and Anil Kamat, MD²

¹Mazumdar Shaw Medical Centre, Narayana Health City, Bengaluru, India
²Immuneel Therapeutics Private Limited, Bengaluru, India

Nirav N. Shah, MD¹, Fateeha Furqan, MD², Aniko Szabo, PhD^3*, Jessica Neumann^2*, Walter L. Longo, MD^1*, Parameswaran Hari, MD, MRCP⁴, Dina Schneider^5*, Bryon Johnson, PhD¹, Timothy S. Fenske, MD² and Mehdi Hamadani, MD¹

¹Department of Hematology & Oncology, Medical College of Wisconsin, Milwaukee, WI
²Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
³Division of Biostatistics, Institute of Health & Equity, Medical College of Wisconsin, Milwaukee, WI
⁴Medical College of Wisconsin, Milwaukee, WI
⁵A Miltenyi Biotec Company, Lentigen Technology Inc., Gaithersburg, MD

Sawa Ito, MD¹, Christine Voigt, PhD^2*, Constantinos Panousis^2*, Tim Mayall, PhD^2*, Mark Shlomchik, MD, PhD^2,3*, Jennifer Roy^2*, Egidio Brocca Cofano^2*, Stephanie Stras^2*, David Apelian, MD, PhD, MBA^2* and Warren D Shlomchik, MD^1,2,3

¹Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA
²BlueSphere Bio, Pittsburgh, PA
³Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA

Jeremy L. Ramdial, MD¹, Lorlyn Clemente-Sevilla^2*, Doris Soebbing^3*, Bouthaina S. Dabaja, MD^4*, Peter F Thall, PhD^5*, Gheath Alatrash, PhD, DO¹, Amin M Alousi, MD¹, Rohtesh S. Mehta, MD¹, Uday R Popat, MD¹, Partow Kebriaei, MD⁶, Betul Oran, MD, MS⁷, Katy Rezvani, MD¹, Elizabeth J Shpall, MD¹ and Richard E Champlin, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Stem cell Transplant, MD Anderson Cancer Center, Houston, TX
³University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Stem Cell Transplantation and Cellular Therapy, University of Texas M.D. Anderson Cancer Center, Houston, TX
⁷Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

Javier Pinilla Ibarz, MD^1,2,3, Amy Lankford, PhD^4*, Helen Sabzevari, PhD^4*, Bijal D. Shah, MD⁵, Hatem Soliman, MD^6*, Julio C. Chavez, MD^5,7 and Rutul R Shah^4*

¹Department of Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
³Moffitt Cancer Center, Tampa, FL
⁴Precigen, Inc, Germantown, MD
⁵Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶Breast Oncology, Moffitt Cancer Center, Tampa, FL
⁷Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL

Miguel-Angel Perales, MD¹, Sairah Ahmed, MD², Saurabh Dahiya, MD³, Peter A. Riedell, MD⁴, Joseph P. McGuirk, DO⁵, Olalekan O. Oluwole, MBBS⁶, Sohail A. Chaudhry, MD^7*, Zachary Lee, PharmD^7*, Stanley Dai^7*, Neha Dixit, PhD^7*, Christie Fanton, PhD^7*, Mario Q. Marcondes, MD, PhD⁷, Jonathan Zalevsky, PhD^7*, Mary A. Tagliaferri, MD^7* and Cameron J. Turtle, MBBS, PhD⁸

¹Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas M D Anderson Cancer Center, Houston, TX
³University – School of Medicine - Hematology/Oncology, Stanford University, Palo Alto, CA
⁴University of Chicago, Chicago, IL
⁵Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁶Vanderbilt University Medical Center, Nashville, TN
⁷Nektar Therapeutics, San Francisco, CA
⁸Fred Hutchinson Cancer Research Ctr., Seattle, WA

Yongxian Hu, M.D., Ph.D.^1,2,3,4*, Jiqin Zhang, PhD^5,6*, Mingming Zhang^2,3,4,7*, Wei Li, PhD^6*, Wenjun Wu, MD^1,3,4,8*, Jiazhen Cui^1,3,4,8*, Guoqing Wei, MD^1,2,3,4*, Bing Du, PhD^5*, Mingyao Liu, PhD^9* and He Huang^1,2,3,4

¹Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Liangzhu Laboratory, Zhejiang University Medical Center, 1369 West Wenyi Road, Hangzhou 311121, China, Hangzhou, China
³Institute of Hematology, Zhejiang University, Hangzhou, China
⁴Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
⁵Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, China
⁶BRL Medicine Inc., Shanghai, China
⁷Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
⁸Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China
⁹Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, Institute of Biomedical Sciences and School of Life Sciences, East China Normal University, Shanghai, TX, China

Paolo Strati, MD¹, Xubin Li^2*, Qing Deng, PhD^3*, Lei Feng, MS^4*, Ryan Sun, MD^5*, Andrew Jallouk, MD, PhD⁶, Sherry Adkins, ANP^7*, Taylor Cain^2*, Swapna Johncy^8*, Raphael E Steiner, MD⁹, Sairah Ahmed, MD¹⁰, Dai Chihara, MD, PhD¹¹, Luis Fayad, MD¹, Swaminathan Padmanabhan Iyer, MD^1*, Sandra B. Horowitz, Pharm.D.^12*, Rachel Nehlsen^2*, Loretta J. Nastoupil, MD⁹, Ranjit Nair, MD¹³, Ahmed Hassan^2*, Taher Daoud^2*, Misha Hawkins^14*, Felipe Samaniego, MD¹, Maria Alma Rodriguez, MD^6*, Elizabeth J Shpall, MD¹⁵, Partow Kebriaei, MD¹⁵, Christopher R. Flowers, MD⁹, David Hong^2*, Jason Westin, MD⁷, Sattva S. Neelapu, MD¹⁶ and Michael R. Green, PhD³

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²MD Anderson Cancer Center, Houston
³Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵UT MD Anderson Cancer Center, Houston, TX
⁶MD Anderson Cancer Center, Houston, TX
⁷The University of Texas MD Anderson Cancer Center, Houston, TX
⁸MD Anderson Cancer Center:, Houston, TX
⁹Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
¹⁰Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas M D Anderson Cancer Center, Houston, TX
¹¹Department of Leukemia, The University of New Mexico Health Sciences Center, Albuquerque, NM
¹²Pharmacy Clinical Programs, University of Texas M.D. Anderson Cancer Center, Houston, TX
¹³Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
¹⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
¹⁵Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁶Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center, Houston, TX

Sairah Ahmed, MD¹, Ian W. Flinn, MD PhD², Matthew Mei, MD³, Peter A. Riedell, MD⁴, Philippe Armand, MD, PhD^5*, Natalie S. Grover, MD⁶, Renu Balyan, PhD^7*, Cliff Ding, PhD^7*, Aung Myo, MD^7*, Ivan D. Horak, MD⁷ and Helen E. Heslop, MD, DSc (Hon)⁸

¹Department of Lymphoma/Myeloma and Stem Cell Transplantation, The University of Texas M D Anderson Cancer Center, Houston, TX
²Tennessee Oncology, Sarah Cannon Research Institute, Nashville, TN
³Division of Lymphoma, City of Hope Medical Center, Duarte, CA
⁴Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁵Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁶Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC
⁷Tessa Therapeutics, Singapore, Singapore
⁸Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX

Danielle K. Sohai, B.S.^1,2, Michael Keller, MD^2,3*, Patrick J. Hanley, PhD^2,3*, Anushree Datar, M.S.^2*, Emily Reynolds, B.S.^2*, Dennis Copertino, B.A.^4*, Chase McCann, MSPH, PhD^2*, Haili Lang, MD^2*, Cecilia Motta, PhD^2*, Andrew Wilson, PhD^5*, Rebecca Lynch, PhD^5*, Winiffer Conce Alberto, B.S.^4*, Zabrina L. Brumme, PhD^6*, Natalie N. Kinloch, B.S.^6*, Conrad Russell Y. Cruz, MD, PhD^2,3, Lynsay MacLaren Ehui, PA-C, MPH, MPAS^7*, Sarah Henn, MD, MPH^7*, R. Brad Jones, PhD^4* and Catherine M Bollard, MD^3,8

¹Institute for Biomedical Sciences, The George Washington University, Washington, DC
²Center for Cancer and Immunology Research, Children's National Hospital, Washington, DC
³Department of Pediatrics, The George Washington University, Washington, DC
⁴Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, NY
⁵Department of Microbiology, Immunology, and Tropical Medicine, The George Washington University, Washington, DC
⁶Faculty of Health Sciences, British Columbia Centre for Excellence in HIV/AIDS, Simon Fraser University, Vancouver, BC, Canada
⁷Whitman-Walker Health, Washington, DC
⁸Center for Cancer and Immunology Research, Children's National Medical Center, Washington, DC